ArticleBMC cancer2022

Nitric-Oxide Synthase trafficking inducer (NOSTRIN) is an emerging negative regulator of colon cancer progression.

Madhurima Paul et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.